Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury
- 7 November 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 351 (4) , 940-946
- https://doi.org/10.1016/j.bbrc.2006.10.166
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ST2 suppresses IL-6 production via the inhibition of IκB degradation induced by the LPS signal in THP-1 cellsBiochemical and Biophysical Research Communications, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Protective strategies against ischemic injury of the liverGastroenterology, 2003
- Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4The Journal of Immunology, 2002
- HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal PathwayJournal of Biological Chemistry, 2002
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4The Journal of Experimental Medicine, 2002
- A Novel Pathway Regulating Lipopolysaccharide-Induced Shock by ST2/T1 Via Inhibition of Toll-Like Receptor 4 ExpressionThe Journal of Immunology, 2001
- Mechanism of Hepatocyte Death After Ischemia: Apoptosis Versus NecrosisHepatology, 2001
- T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector functionProceedings of the National Academy of Sciences, 1998
- Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T CellsThe Journal of Experimental Medicine, 1998